Targeting Hyaluronan Interactions for Glioblastoma Stem Cell Therapy

Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

(2018) Sabine Hombach-Klonisch et al.   PHARMACOLOGY & THERAPEUTICS

Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20)

(2017) Kit Man Wong et al.   Current Oncology Reports

Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment

(2017) Vivian Adamski et al.   Oncotarget

A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics

(2016) Donglai Lv et al.   Oncotarget

Nonsurgical treatment of recurrent glioblastoma

(2015) O. Gallego   Current Oncology

Extracellular Matrix Properties Regulate the Migratory Response of Glioblastoma Stem Cells in Three-Dimensional Culture

(2015) Marisol Herrera-Perez et al.   TISSUE ENGINEERING PART A

Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy

(2015) H. Michael Shepard   Frontiers in Oncology

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy

(2014) B Auffinger et al.   CELL DEATH AND DIFFERENTIATION

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

(2014) Olivier L. Chinot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hyaluronan: Towards novel anti-cancer therapeutics

(2014) Michał S. Karbownik et al.   Pharmacological Reports

Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP

(2014) Orieta Celiku et al.   PLoS One

A restricted cell population propagates glioblastoma growth after chemotherapy

(2012) Jian Chen et al.   NATURE

In vitro three-dimensional (3D) models in cancer research: An update

(2011) Lauren C. Kimlin et al.   MOLECULAR CARCINOGENESIS

Targeting the Tumor Microenvironment in Cancer: Why Hyaluronidase Deserves a Second Look

(2011) C. J. Whatcott et al.   Cancer Discovery

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Hyaluronan in human malignancies

(2010) R.K. Sironen et al.   EXPERIMENTAL CELL RESEARCH

NF-κB and STAT3 signaling in glioma: targets for future therapies

(2010) George P Atkinson et al.   Expert Review of Neurotherapeutics

Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation

(2010) Kaoru Tamura et al.   JOURNAL OF NEUROSURGERY

Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models

(2010) C. B. Thompson et al.   MOLECULAR CANCER THERAPEUTICS

Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth

(2010) Sonia Guedan et al.   MOLECULAR THERAPY

Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities

(2009) B. P. Toole   CLINICAL CANCER RESEARCH

Two Novel Functions of Hyaluronidase-2 (Hyal2) Are Formation of the Glycocalyx and Control of CD44-ERM Interactions

(2009) Cecile Duterme et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays

(2009) Yifang Hu et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111

(2009) Gregory K. Friedman et al.   JOURNAL OF NEURO-ONCOLOGY

Association between cancer and “acid mucopolysaccharides”: An old concept comes of age, finally

(2008) Robert Stern   SEMINARS IN CANCER BIOLOGY